ANN ARBOR, Mich., Dec. 12, 2013 /PRNewswire/ -- Rubicon Genomics, Inc., (Rubicon), a leader in the development and commercialization of innovative nucleic acid library preparation products used in research and clinical testing, today announced that it has partnered with additional distributors globally to expand availability of its products, including ThruPLEX®-FD Prep Kits and PicoPLEX™-WGA Kits.
Three new distribution partnerships have been signed for Europe. They include Amplitech for France, HPST for the Czech Republic and LuBio Science for Switzerland. Rubicon also completed new distribution agreements in Asia and the Middle East. They include Recenttec for Japan, Prisma Biotech for Taiwan and S.M. Chemical for Thailand. Custom Science will provide distribution services to Australia and New Zealand. A well-established local biomedical distributor is supporting sales of Rubicon's products in Qatar.
James Koziarz, PhD, CEO of Rubicon Genomics, commented, "These agreements reflect our strategy of enhancing our existing global distribution channel by partnering with companies that know their local markets and are able to provide a high level of technical service and support. They extend our reach in growing sequencing markets around the globe and enable our customers to access our products without the additional cost and complications of shipping from the US to global destinations."
ThruPLEX®-FD Prep Kits for Illumina® NGS platforms streamline library preparation for fragmented DNA/cDNA and reduce sample input amounts to picogram levels. ThruPlex-FD's patented technology delivers a highly efficient and user-friendly process that takes place in a single tube in less than 2 hours. ThruPLEX-FD provides consistent and reliable results for applications including DNA-seq, RNA-seq and ChiP-seq and is especially useful for clinical samples such as plasma and FFPE.
PicoPLEX™-WGA Kits amplify DNA to yield a highly reproducible library from a single cell. The product is widely used in the IVF market to identify aneuploidy and copy number variation. PicoPLEX WGA's patented technology is optimized for amplification of single copy genomic DNA with input concentrations as low as 15 picograms. The easy-to-use single tube protocol reduces handling errors and background and dramatically improves time to results.
More information on Rubicon's distributors can be found at: http://rubicongenomics.com/how-to-buy/distributors/.
About Rubicon Genomics
Rubicon Genomics, Inc. is a leader in the development and commercialization of innovative sample-specific nucleic acid library preparation products used in research and clinical testing on NGS, microarray, and q-PCR platforms. The company's core competency is the creation of more efficient molecular biology tools for genetic, epigenetic and expression analysis of difficult clinical samples to facilitate gene-based research, drug development and diagnostics. Privately-held Rubicon is located in Ann Arbor, Michigan. For more information, visit www.rubicongenomics.com.Contacts:
MediaRubicon GenomicsBarbara LindheimJamie Wibbenmeyer, PhDBLL Partners, LLCBusiness Development(212) email@example.com
|SOURCE Rubicon Genomics|
Copyright©2012 PR Newswire.
All rights reserved